Skip to main content
Log in

Does megestrol acetate down-regulate interleukin-6 in patients?

  • Letter To The Editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Jatoi A, Yamashita J, Sloan JA, Novotny PJ, Windschitl HE, Loprinzi CL (2002) Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Support Care Cancer 10:71–75

    Article  PubMed  Google Scholar 

  2. Mantovani G, Macciò A, Bianchi A, et al (1995) Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy. Int J Clin Lab Res 25:135–141

    Article  CAS  PubMed  Google Scholar 

  3. Mantovani G, Macciò A, Mura L, et al (2001) Serum values of proinflammatory cytokines inversely correlate with serum leptin levels in patients with advanced stage cancer at different sites. J Mol Med 79:406–414

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giovanni Mantovani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mantovani, G. Does megestrol acetate down-regulate interleukin-6 in patients?. Support Care Cancer 10, 566–567 (2002). https://doi.org/10.1007/s00520-002-0351-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-002-0351-6

Keywords

Navigation